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Introduction: Carbon monoxide poisoning can be associated with life-threatening complications, including
significant and disabling cardiovascular and neurological sequelae.
Case presentation: We report a case of carbon monoxide poisoning in a 25-year-old Saudi woman who presented
to our facility with status epilepticus and cardiopulmonary arrest. Her carboxyhemoglobin level was 21.4 percent.
She made a full recovery after we utilized a neuroprotective strategy and normobaric oxygen therapy, with no
delayed neurological sequelae.
Conclusions: Brain protective modalities are very important for the treatment of complicated cases of carbon
monoxide poisoning when they present with neurological toxicities or cardiac arrest. They can be adjunctive to
normobaric oxygen therapy when the use of hyperbaric oxygen is not feasible.
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Carbon monoxide (CO) poisoning remains one of the most
difficult medical emergencies to diagnose because of its
non-specific and variable clinical presentation [1]. In Saudi
Arabia, accidental (as opposed to deliberate, that is,
suicidal) exposure usually results from smoke inhalation
from charcoal fires used for heating in rooms that are
poorly ventilated during the winter season.
In our report, we describe the presentation and suc-
cessful management of a woman with significant CO
poisoning. We highlight the specific interventions that
were employed to safeguard a favorable outcome by
using a neuroprotective strategy. We also review the
subject in general and advocate a systematic approach
to its management based on available local resources.
Our patient presented with status epilepticus and* Correspondence: dr-salman@hotmail.com
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reproduction in any medium, provided the orcardiopulmonary arrest. She was successfully managed by
cerebral protection and normobaric oxygen therapy.Case presentation
A 25-year-old Saudi woman with no previous medical ill-
ness was brought to the Emergency Department at 8.00 a.
m. after being found unresponsive, two hours earlier, at
home. She had placed a charcoal fire at her bedside
since midnight to warm her room. On arrival to her
room, family members found her having brief abnormal
generalized body movements and she was unresponsive.
There was no history of psychiatric illness, drug misuse,
previous suicidal attempts or epilepsy.
On arrival to our Emergency Room, she was comatose
with a Glasgow Coma Scale (GCS) score of 3/15. A vital
signs examination revealed an oral temperature of 37.0°C,
a regular pulse of 114 beats/minute, blood pressure of
127/98mmHg and a respiratory rate of 24 breaths/minute.
Her pulse oximetry was 99 percent on room air. Other-
wise the results of her general routine examination were
unremarkable.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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were normal. Her hemoglobin (Hb) level was 135g/L,
and her leukocyte count was 22×109 cells/L with neutro-
philia. Her creatinine kinase level was 6489U/L (normal
range 38 to 174U/L), creatinine kinase-MB isoenzyme
level 143.5U/L (normal range 0.20 to 5.00U/L), aspartate
aminotransferase 128U/L (normal range 15 to 40U/L),
lactate dehydrogenase 459U/L (normal range 100 to
190U/L) and troponin I was 4.69ng/L (normal range
<0.10ng/L). The results of urine toxicology screening
tests, including tests for benzodiazepines, cannibinoids,
amphetamines, opiates and cocaine, were negative.
Her arterial blood gases on a non-rebreather facial mask
at 15L/min oxygen showed pH 7.35, PaCO2 36.2mmHg,
PaO2 348.9mmHg, HCO
3- 19mmol/L, SaO2 99.8 percent
and carboxyhemoglobin (COHb) of 21.4 percent.
An electrocardiogram (ECG) showed sinus tachycardia
with no ST segment changes. The results of a brain
computed tomography (CT) scan were normal.
The initial impression was of severe carbon monoxide
poisoning associated with coma, hypoxic rhabdomyolysis
and cardiac muscle injury.
Endotracheal intubation was instituted because of her
low GCS. Soon after, she started to have a generalized
tonic-clonic seizure that continued for approximately 50
minutes despite frequent intravenous doses of benzodia-
zepines and intravenous phenytoin loading. Her convul-
sions finally abated after adding thiopental (100mg
intravenously) to the regiment. Soon after that she
developed asystole. Sinus rhythm and a recordable blood
pressure were re-attained following a 10-minute cardio-
pulmonary resuscitation. She had not had an electro-
encephalogram (EEG) during the time of her clinical
seizure but a subsequent EEG showed α-coma waves
and bilateral sharp epileptiform discharges with no signs
of status epilepticus.
In our Intensive Care Unit (ICU), she was mechanically
ventilated with FiO2 100 percent and her COHb level
normalized after 54 minutes. We used our hospital
protocol for severe traumatic brain injury, which is
compatible with the Brain Trauma Foundation protocol
(2007), in order to achieve brain protection [2]. The
protocol included the following:
(1) management of airway and breathing by early
intubation and mechanical ventilation, which was
adjusted to maintain a pulse oximetry ≥95 percent
and/or PaO2 ≥80mmHg and eucapnea with PCO2 of
35 to 40mmHg;
(2) maintaining euvolemia using isotonic fluid to keep
central venous pressure equal 8 to 10mmHg;
(3) inotropes to maintain mean arterial pressure (MAP)
above 80mmHg;
(4) moderate hypothermia (32°C to 34°C);(5) maintaining normoglycemia (8.1 to 10mmol/L);
(6) intravenous phenobarbitone and phenytoin to
prevent seizure recurrence and intravenous fentanyl
and midazolam for sedation.
An echocardiogram showed normal left ventricular
function and no regional wall abnormalities. A repeat
EEG on day seven revealed no evidence of status epilep-
ticus; however, it showed evidence of a moderate degree
of encephalopathy that was attributed to multiple factors
that would, possibly, include a previous CO poisoning
and hypoxic event, on top of the effect of medications
used (that is, midazolam, phenytoin and phenobarbitone),
since a repeated CT scan of the brain and repeat
electrolyte test results were normal.
She remained on mechanical ventilation for 13 days.
This was complicated by ventilator-associated pneumonia.
She was successfully extubated and started on an intensive
rehabilitation program with rapid improvement. She was
discharged home fully independent in physical function. A
brain magnetic resonance imaging (MRI) scan did not
show any signs of CO poisoning three weeks after her ini-
tial presentation. A cognitive function assessment was not
performed by a psychologist at that time since her mental
and psychological functions were recovering significantly.
She returned back to work as an office secretary two
months after the event with excellent and complete func-
tional recovery and no neurological or psychological defi-
cits. Our patient cordially agreed to attend our clinical
meeting discussing her case presentation and manage-
ment. She confirmed to the audience that she felt both
physically and cognitively back to her normal self. Subse-
quently, she actively participated in an awareness cam-
paign for CO poisoning. Currently, she is a postgraduate
student studying abroad.
Discussion
CO is a non-irritant, colorless, odorless and tasteless gas
that is commonly produced by the incomplete combus-
tion of carbon-rich fuel [1]. Its remarkable affinity to
hemoglobin (250 times more binding) displaces oxygen,
reduces hemoglobin oxygen-carrying capacity and results
in tissue hypoxia [1]. The latter event, coupled with a dir-
ect mitochondrial electron transfer dysfunction, culmi-
nates in a pathological, hypoxia-driven cascade of events
responsible for the short-term and long-term complica-
tions of CO poisoning [1].
Symptomatology, ranging from headache and dizziness
progressing to convulsions, coma or cardiopulmonary
arrest and death, are directly related to the degree and
severity of poisoning. Later complications in survivors in-
clude extrapyramidal dysfunction and neuropsychiatric and
cognitive difficulties. Early suspicion and diagnosis, high-
dose oxygen supplementation proceeding to hyperbaric
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monary and metabolic support are the mainstays of a
successful treatment and good outcome [1,3].
CO poisoning requires prompt management once it is
diagnosed. The clinical assessment of the patient should
include proper airway management and ventilation in
addition to maintenance of hemodynamic stability [1].
Administration of high-flow oxygen should be initiated
by emergency personnel before arrival at the hospital.
Normobaric oxygen should be continued until the
COHb level is less than 5 percent [1]. However, some
hyperbaric oxygen (HBO) therapy experts prefer to
lower the COHb level to less than 2 percent because
some patients can have a rebound shift of CO from soft
tissues into the circulation.
Essential preliminary assessment parameters should
include: duration and source of exposure, a complete
neurological examination, measurement of arterial blood
gases looking specifically for the COHb level (this is be-
cause pulse oximetry cannot differentiate between carb-
oxyhemoglobin and oxyhemoglobin), and identification
of significant metabolic acidosis [3].
The COHb level depends on many factors such as the
duration of exposure, the alveolar ventilation and blood
volume [4]. The atmospheric concentration of CO is 0.1
percent. Levels in non-smokers are between 3 percent to
5 percent, while smokers may have higher levels reaching
6 percent to 8 percent [5]. The clinical symptoms may not
necessarily correlate with the COHb level. They are
thought to be a product of an inflammatory process that
is initiated by the CO poisoning.
CO elimination is related to the fraction of inspired oxy-
gen. The half-life of COHb is 250 minutes if the patient is
breathing room air, 90 minutes if the patient is on 100
percent oxygen 200kPa and 35 minutes if on 100 percent
oxygen 300kPa [6].
CT or MRI studies may be used to assess the presence
of an acute ischemic brain injury if performed six hours or
more following a significant CO exposure. Acutely, the
commonest finding on neuroimaging is cerebral edema,
while post-acute stage MRI T2-weighted imaging may
show hyperintensities in the basal ganglia and atrophy in
the hippocampi [7,8]. Basal ganglia lesions were found in
4 percent to 88 percent of patients in a prospective study
of 73 patients by Hopkins et al. commonly of the globus
pallidus. These are reported at one month and up to five
years after CO poisoning [9].
In addition to cardiac toxicity, CO poisoning has been
associated with several serious neurological complica-
tions such as amnesia, encephalopathy, dysarthria,
brain hemorrhage, supranuclear gaze palsy, peripheral
neuropathy and parkinsonism [10].
To date, only one case of non-convulsive status epilepti-
cus secondary to acute CO poisoning has been reportedin the English literature. The patient in that case was trea-
ted by HBO therapy but unfortunately the patient died of
sepsis with multi-organ failure [11]. Our patient had se-
vere CO poisoning manifested by coma, status epilepticus
and cardiac arrest. Her COHb level was 21.4 percent,
which was obtained two hours later after removal of
our patient from the source of the exposure; there-
fore, the real COHb level during exposure was much
higher considering the fast elimination of CO gas.
Her refractory seizures, likely related to global cere-
bral hypoxia secondary to CO poisoning, abated after
adding intravenous thiopental therapy to phenytoin
and midazolam regiment. Hyperbaric oxygen was not
utilized in our patient’s case as it was not available in our
institution and our patient’s condition was initially too
unstable for transfer to another facility.
Hyperbaric oxygen therapy is defined as the breathing
of 100 percent oxygen within hyperbaric chambers at 1.4
times atmospheric pressure [12].
Hyperbaric oxygen has a neuroprotective effect as it
leads to cerebral vasoconstriction, thereby reducing cere-
bral edema [13]. Earlier use of HBO contributes to a
better outcome [14]. It is specifically indicated for vic-
tims of carbon monoxide poisoning presenting with
coma, seizures or cardiac arrhythmia [15]. HBO was
clearly indicated in our patient. However she made a full
recovery with normobaric oxygen (NBO) treatment
delivered by conventional mechanical ventilation.
HBO versus NBO treatment has been studied in
human patients in only few randomized clinical trials.
Most of them included acute presentations of non-
comatose patients. No difference in the short-term
outcome between HBO and NBO was found [16].
Scheinkestel and colleagues found HBO therapy did
not benefit, and may have worsened, the outcome in the
learning test at completion of treatment. Delayed neuro-
logical sequelae were restricted to HBO patients and no
outcome measure was worse in the NBO group [17].
Weaver et al. performed a double-blinded, randomized
trial of hyperbaric oxygen compared with normobaric
oxygen therapy in acute CO poisoning. The trial was
stopped prematurely after an interim analysis showed
that patients treated with hyperbaric oxygen had less fre-
quent cognitive dysfunction compared with patients
treated with normoxia which was persistent at 12
months of follow-up [18].
A 2011 Cochrane meta-analysis review of all rando-
mized trials did not establish whether administration of
HBO to victims of CO poisoning reduced the incidence
of neurological late sequelae [19].
In one study, HBO was found to be most appropriate
and beneficial for patients with acute CO poisoning who
are 36 years or older or have an exposure interval of
more than 24 hours. Loss of consciousness and higher
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randomized controlled trial. Of 163 patients who did not
receive HBO, 42 percent had cognitive complications [20].
Narcotics such as fentanyl and morphine are consid-
ered for cases of severe traumatic brain injury as they
provide analgesia, mild sedation and cough suppression,
which might elevate the intra-cranial pressure (ICP) in
intubated and mechanically ventilated patients. Sedation
can potentiate the effect of analgesia because of the
anxiolytic effect and prevention of elevation of ICP due
to agitation, discomfort, cough, pain, facilitating nursing
care and mechanical ventilation. Narcotics with sedative
medications could decrease the oxygen consumption
and carbon dioxide production as well, which affects the
ICP [21].
Barbiturates are proven to be effective for status epi-
lepticus treatment and decreasing ICP by reducing the
cerebral metabolism and cerebral blood flow [21].
Hypotension has been associated with poor outcome
post-traumatic brain injury, therefore adequate volume
resuscitation by isotonic fluid to achieve euvolemia
and initiating vasopressor infusion to maintain MAP
≥80mmHg may be helpful to maintain cerebral perfusion
pressure within normal limits [21].
Hyperglycemia is an important insult to the brain due
to stress after severe brain injury. It can lead to cerebral
edema and poor neurological outcome [21].
Additionally, hypothermia was helpful in our patient
because it is able to reduce the metabolic rate in brain
cells, the oxygen demand and cerebral edema. It may also
ameliorate toxic metabolites and free radical formation.
The risks of hypothermia use include infection, coagulo-
pathy and arrhythmias [21-23].
Despite the aggressive presentation in our patient’s
case, with status epilepticus and cardiac arrest, she made
a full recovery with normobaric oxygen therapy. Based
on our experience, we believe that normobaric mechan-
ical ventilation when accompanied by proper methods of
central nervous system protection (hypothermia, normo-
glycemia, phenobarbital) can be an option for CO poi-
soning victims if hyperbaric oxygen therapy is not
available.Conclusions
In summary, we report a case of severe carbon monoxide
poisoning presenting with status epilepticus and cardiac
arrest. Our patient was treated with normobaric oxygen
therapy and strict neuroprotection with a full functional
recovery. The findings in the present case suggest that
normobaric high concentration of oxygen coupled with
neuroprotection may be a therapeutically adequate alter-
native to hyperbaric oxygen for the treatment of severe
CO poisoning.Consent
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